EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical

Advancing Towards Human Challenge Studies with the SARS-CoV-2 Virus

The current COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, is the current focus of numerous drug therapies and vaccine candidates. We have seen swift action from regulatory authorities to fast-track clinical programmes to find a cure or treatment. However, Bruno Speder and Robin Rogiers at SGS question whether it would it be possible that human challenge testing – or controlled infection models – could offer insights into developing therapies.

 

Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18